Cholangiocarcinoma is a rare form of bile duct cancer which affects upwards of 1,000 Brits every year, and can display an usual symptom ...

"People come in with a lump. Sometimes it can be something benign, like a cyst, but it can also be a cancer." Not all warning signs are obvious, however. "It's not just about feeling a lump," Saphier ...

Medically reviewed by Jay N. Yepuri, MDMedically reviewed by Jay N. Yepuri, MD Bile duct cancer, also known as ...

Age, sex, diet, and more can play a role in gallstones and other gallbladder diseases. Learn more about the risk factors.

There is good and bad in all of us. Similarly, no zodiac signs are either totally excellent or completely bad. In astrology, there is a balance between mild and intense behavioural traits ...

Due to its rarity, male breast cancer is often diagnosed at a later stage, which can make treatment more challenging. In this article, we share a list of causes, signs and prevention tips for male ...

Oct 18 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the ...

After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy as a bladder cancer treatment in the U.S. The California biotech announced the decision ...

(Reuters) -Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the main goal in a confirmatory trial.

In May, Gilead Sciences announced topline results from the confirmatory Phase 3 TROPiCS-04 study in locally advanced or metastatic urothelial cancer (mUC). The TROPiCS-04 study evaluated Trodelvy ...

The move is a blow to Gilead’s cancer portfolio. Trodelvy, an antibody-drug conjugate granted accelerated approval for bladder cancer in 2021, failed its confirmatory trial earlier this year. Gilead ...